 Which insiders are confident in their companies? Top 5 purchases for May 15 Every Friday, I collect data on insider trades — and today there are several deals that really catch the eye. Insiders (directors, CEOs, large funds) vote with their money, and when they buy millions, it's a signal. Pulse Biosciences (PLSE) — $13 million Robert Duggan (legendary investor who made $3.6 billion on Pharmacyclics) bought 660,000 shares at $19.69. Duggan doesn't throw money around. Biotech with unique technology is his forte. Genedx Holdings (WGS) — $13.76 million Keith Meister (Corvex Management) increased his stake by 7%. Genetic testing is a growing market, and Meister clearly sees undervaluation. On Holding AG (ONON) — $6.6 million (total) Three top managers of the company (including both Co-CEOs) synchronously bought 60,000 shares each at $36.64. When the entire C-level team buys simultaneously, it's not a coincidence. Nomad Foods (NOMD) — $912 thousand A director bought 100,000 shares, increasing his stake by 20%. Price $9.13 — near historical lows. A bet on a turnaround. Sensei Biotherapeutics (SNSE) — $818 thousand Millennium Management increased its stake by 27%. An early-stage biotech company — high risk, but the fund clearly sees potential. What this means for us: Insiders buy when they think their shares are cheap. Mass synchronous purchases (like in ONON) are one of the strongest signals. Duggan and Meister are investors with long track records; their entries are worth tracking. Full list of 25 deals — in my note. Follow insiders; they know their companies better than analysts. #insiders #investing #stockmarket #insidertrading